Vicki Gill
Overview
Explore the profile of Vicki Gill including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
267
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hamoodi Z, Shapiro J, Sayers A, Whitehouse M, Watts A, Abbott J, et al.
Bone Joint J
. 2024 Dec;
106-B(12):1461-1468.
PMID: 39618239
Aims: The aim of this audit was to assess and improve the completeness and accuracy of the National Joint Registry (NJR) dataset for arthroplasty of the elbow. Methods: It was...
2.
Vasdev S, Singal P, Gill V
Int J Angiol
. 2012 Apr;
18(1):7-21.
PMID: 22477470
Hypertension is a leading cause of morbidity and mortality worldwide. Individuals with hypertension are at an increased risk for stroke, heart disease and kidney failure. Essential hypertension results from a...
3.
Vasdev S, Gill V
Int J Angiol
. 2012 Apr;
17(1):7-22.
PMID: 22477366
Hypertension is a leading cause of morbidity and mortality worldwide. Individuals with hypertension are at increased risk of stroke, heart disease and kidney failure. Although the etiology of essential hypertension...
4.
Singh S, Dhingra S, Ramdath D, Vasdev S, Gill V, Singal P
J Cardiovasc Transl Res
. 2010 Jul;
3(5):580-96.
PMID: 20593256
Type 2 diabetes (T2DM) and its complications such as cardiomyopathy, contribute significantly to morbidity and mortality worldwide. Increased adoption of westernized diets and decreased physical activity are contributing to the...
5.
Han Y, Randell E, Vasdev S, Gill V, Curran M, Newhook L, et al.
Clin Biochem
. 2009 Jan;
42(7-8):562-9.
PMID: 19154730
Objectives: Elevated advanced glycation endproducts (AGEs) are implicated in diabetic complications. Methylglyoxal-derived hydroimidazolone (MG-H) is one of the most abundant AGEs in vivo. Our objective was to develop a time-saving,...
6.
Vasdev S, Gill V, Singal P
Cell Biochem Biophys
. 2007 Sep;
49(1):48-63.
PMID: 17873339
The vascular diseases, hypertension and atherosclerosis, affect millions of individuals worldwide, and account for a large number of deaths globally. A better understanding of the mechanism of these conditions will...
7.
Vasdev S, Gill V, Parai S, Gadag V
Can J Physiol Pharmacol
. 2007 Jul;
85(3-4):413-21.
PMID: 17612650
We investigated the effects of 4% fructose plus moderately high salt (MHS) (4% NaCl) treatment on tissue aldehyde conjugates, platelet cytosolic free calcium ([Ca2+]i), renal morphology, and systolic blood pressure...
8.
Han Y, Randell E, Vasdev S, Gill V, Gadag V, Newhook L, et al.
Mol Cell Biochem
. 2007 Jun;
305(1-2):123-31.
PMID: 17594057
The reactive aldehydes methylglyoxal and glyoxal, arise from enzymatic and non-enzymatic degradation of glucose, lipid and protein catabolism, and lipid peroxidation. In Type 1 diabetes mellitus (T1DM) where hyperglycemia, oxidative...
9.
Vasdev S, Gill V, Singal P
Vasc Health Risk Manag
. 2007 Mar;
2(3):263-76.
PMID: 17326332
Low ethanol intake is known to have a beneficial effect on cardiovascular disease. In cardiovascular disease, insulin resistance leads to altered glucose and lipid metabolism resulting in an increased production...
10.
Sun G, Bishop J, Khalili S, Vasdev S, Gill V, Pace D, et al.
Am J Clin Nutr
. 2007 Feb;
85(2):399-404.
PMID: 17284735
Background: Visfatin is an insulin-mimicking adipokine. Visfatin is elevated in obesity and type 2 diabetes. However, its role in glucose and lipid metabolism in healthy humans is unclear. Objective: The...